AU1559899A - Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field - Google Patents

Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field

Info

Publication number
AU1559899A
AU1559899A AU15598/99A AU1559899A AU1559899A AU 1559899 A AU1559899 A AU 1559899A AU 15598/99 A AU15598/99 A AU 15598/99A AU 1559899 A AU1559899 A AU 1559899A AU 1559899 A AU1559899 A AU 1559899A
Authority
AU
Australia
Prior art keywords
biomedical
hyaluronic acid
ester derivatives
viscoelastic properties
healthcare field
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15598/99A
Inventor
Lanfranco Callegaro
Alessandra Pavesio
Davide Renier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anika Therapeutics SRL
Original Assignee
Fidia Advanced Biopolymers SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers SRL filed Critical Fidia Advanced Biopolymers SRL
Publication of AU1559899A publication Critical patent/AU1559899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU15598/99A 1997-11-06 1998-11-05 Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field Abandoned AU1559899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97PD000253A IT1296689B1 (en) 1997-11-06 1997-11-06 ESTERE DERIVATIVES OF HYALURONIC ACID HAVING VISCOELASTIC PROPERTIES AND THEIR USE IN THE BIOMEDICAL-HEALTH FIELD
ITPD97A0253 1997-11-06
PCT/EP1998/007020 WO1999024070A2 (en) 1997-11-06 1998-11-05 Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field

Publications (1)

Publication Number Publication Date
AU1559899A true AU1559899A (en) 1999-05-31

Family

ID=11391956

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15598/99A Abandoned AU1559899A (en) 1997-11-06 1998-11-05 Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field

Country Status (3)

Country Link
AU (1) AU1559899A (en)
IT (1) IT1296689B1 (en)
WO (1) WO1999024070A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302534B1 (en) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl INJECTABLE, BIOCOMPATIBLE AND BIODEGRADABLE COMPOSITIONS INCLUDING AT LEAST A DERIVATIVE OF HYALURONIC ACID, CHONDROGENIC CELLS, FOR
FR2794763B1 (en) * 1999-06-08 2001-08-24 Centre Nat Rech Scient NOVEL HYALURONIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE
WO2001028602A1 (en) * 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations of hyaluronic acid for delivery of osteogenic proteins
EP1481695A1 (en) * 1999-10-15 2004-12-01 Genetics Institute, LLC Formulations of hyaluronic acid for delivery of osteogenic proteins
US20040037810A1 (en) * 2000-05-03 2004-02-26 Dennis Von Heimburg Biomaterials comprised of preadipocyte cells for soft tissue repair
KR20040011426A (en) * 2000-11-06 2004-02-05 알콘, 인코퍼레이티드 Non-aspirating transitional viscoelastics for use in surgery
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
EP1519744A4 (en) 2002-05-17 2007-10-03 Wyeth Corp Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
FR2850282B1 (en) 2003-01-27 2007-04-06 Jerome Asius INJECTABLE IMPLANT BASED ON CERAMIC FOR THE FILLING OF WRINKLES, CUTANEOUS DEPRESSIONS AND SCARS, AND ITS PREPARATION
US20100098772A1 (en) * 2008-10-21 2010-04-22 Allergan, Inc. Drug delivery systems and methods for treating neovascularization
IT1395392B1 (en) * 2009-08-27 2012-09-14 Fidia Farmaceutici VISCOELASTIC FROSTS LIKE NEW FILLERS
CN104725529A (en) * 2013-12-19 2015-06-24 上海建华精细生物制品有限公司 Hyaluronic acid derivative synthesis method
CZ2016827A3 (en) * 2016-12-23 2018-02-07 Contipro A.S. An ophthalmic preparation
IT201900019762A1 (en) * 2019-10-24 2021-04-24 Fidia Farm Spa Pharmaceutical composition for use in the treatment of cystitis of various etiology

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (en) * 1988-05-13 1990-05-18 Fidia Farmaceutici SELF-CROSS-LINKED CARBOXYLY POLYSACCHARIDES
IT1281886B1 (en) * 1995-05-22 1998-03-03 Fidia Advanced Biopolymers Srl PROCESS FOR THE PREPARATION OF HYDROGELS OBTAINED FROM CHEMICAL DERIVATIVES OF HYALURONIC ACID BY MEANS OF ULTRAVIOLET IRRADIATION AND THEIR
IT1288290B1 (en) * 1996-06-21 1998-09-11 Fidia Spa In Amministrazione S SELF-LETICULATED HYALURONIC ACID AND RELATED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ARTHROPATHIES

Also Published As

Publication number Publication date
ITPD970253A0 (en) 1997-11-06
WO1999024070A2 (en) 1999-05-20
IT1296689B1 (en) 1999-07-14
ITPD970253A1 (en) 1999-05-06
WO1999024070A3 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
AU775126C (en) Substituted oxazolidinones and their use in the field of blood coagulation
AU2084092A (en) Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery
AU1559899A (en) Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field
AU6566094A (en) Heterocyclic derivatives in the treatment of ischaemia and related diseases
AU6614900A (en) Vascular filter having articulation region and methods of use in the ascending aorta
AU2543795A (en) Methods of in vivo gene delivery
AU2003210321A1 (en) Use of sugar esters in cosmetic and/or pharmaceutical preparations
AU5766796A (en) Injectable hyaluronic acid-containing dual-phase composition s, particularly useful in corrective and plastic surgery
AU2103097A (en) Cinnoline derivatives and use as medicine
WO2002083921A8 (en) Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU3021001A (en) Thiazolidine carboxylic acid derivatives and their use in the treatment of cancer
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
AU5836498A (en) N-acyl-hydroxyamino acid esters and their use
AU5116100A (en) Connector and method of use of the connector
AU7448198A (en) Compositions and means for the treatment of burns and other cutaneous traumas
AU1776501A (en) Bifunctional molecules and their use in the disruption of protein-protein interactions
AU6625698A (en) Novel salicylic acid derivatives and their use in cosmetic or dermatological compositions
AU2554595A (en) Compositions and uses thereof in the diagnosis of psoriasis
AUPQ480399A0 (en) Unsaturated fatty acids and their uses in therapy
AU5773794A (en) 4-amino-3-hydroxycarboxylic acid and their use as anitvirals
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
AU4073299A (en) Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
AU1031397A (en) Human peptide circulating in the blood and possessing insulinotropic properties

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase